Biotech China 2014

Oncology: Baylor University

Total Score People Score Events Score
13 9 7
Date Event Presentation Speakers
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Human DC Subsets in Cancer Jacques Banchereau
October 16, 2009 Eighth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy Update on Adjuvant Endocrine Therapies Stephen E. Jones
ER Plasticity Rachel Schiff
Endocrine Therapy in HER2-Driven Breast Cancer: Is it Effective? Rachel Schiff
Do Steroid Hormones Drive ER-Negative Breast Cancer? Suzanne AW Fuqua
COX-2 and Other New Molecular Targets in Breast Cancer Treatment and Prevention Powel H. Brown
July 22, 2009 Eighth International Congress on the Future of Breast Cancer Targeting Metastases Joyce O'Shaughnessy
Welcome and Introductions Joyce O'Shaughnessy
Clinical Dilemma: Is Endocrine Therapy of Benefit in HER2-Driven Breast Cancer? Rachel Schiff
HER2-Driven Breast Cancer Joyce O'Shaughnessy
Triple-Negative Breast Cancer Joyce O'Shaughnessy
New Insights into Adjuvant Chemotherapy Joyce O'Shaughnessy
Hormone-Responsive Breast Cancer Joyce O'Shaughnessy, Suzanne AW Fuqua, Stephen E. Jones
Plasticity of the Estrogen Receptor Rachel Schiff
January 21, 2009 Advances in Prostate Cancer Research SESSION 1: ANIMAL MODELS David M Spencer
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Hypersensitive Estrogen Receptor in Premalignant Breast :Track 2-2 Suzanne AW Fuqua
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Split Session D: Theories on Diet and Lifestyle Behavior Change to Lower Cancer Risk John P Foreyt
October 30, 2008 44th ASCO Annual Meeting General Session III: Challenges Importing Biomarkers into Clinical Trials Susan G Hilesenbeck
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.